$26.01
-0.39-1.47%
al cierre: -
$25.75
-0.26-0.99%
After hour: Jun 4, 8:21 AM EDT
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH)
Ticker | Name | Share % | |
---|---|---|---|
PFE | Pfizer, Inc. | 7.38% | |
ABBV | Abbvie Inc. | 7.14% | |
JNJ | Johnson & Johnson | 7.45% | |
BMY | Bristol-Myers Squibb Co. | 6.25% | |
MRK | Merck & Company, Inc. | 6.90% | |
UTHR | United Therapeutic | 3.61% | |
AMGN | Amgen Inc. | 3.65% | |
VRTX | Nvaesrtex Pharmaceuticals Inc | 4.02% | |
REGN | Regeneron Parmaceuticals Inc. | 3.93% | |
GILD | Gilead Sciences Inc | 3.90% | |
CAH | Cardinal Health Inc. | 4.32% | |
JAZZ | Jazz Pharmaceuticals Plc | 3.95% | |
LLY | Eli Lilly & Co. | 3.86% | |
ZTS | Zoetis Inc . | 3.75% | |
BIIB | Biogen Inc. Com | 3.61% | |
VTRS | Viatris | 3.89% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
FTXH sigue un estilo de inversión Large Cap Blend.
Las principales posiciones de FTXH incluyen: PFE (7.38%), ABBV (7.14%), JNJ (7.45%), BMY (6.25%), MRK (6.9%). Estas representan las mayores posiciones en la cartera del ETF.
Los datos del volumen medio diario para FTXH no están disponibles actualmente.